These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
709 related items for PubMed ID: 15504828
1. Antipneumococcal activities of two novel macrolides, GW 773546 and GW 708408, compared with those of erythromycin, azithromycin, clarithromycin, clindamycin, and telithromycin. Matic V, Kosowska K, Bozdogan B, Kelly LM, Smith K, Ednie LM, Lin G, Credito KL, Clark CL, McGhee P, Pankuch GA, Jacobs MR, Appelbaum PC. Antimicrob Agents Chemother; 2004 Nov; 48(11):4103-12. PubMed ID: 15504828 [Abstract] [Full Text] [Related]
2. Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae. Kosowska K, Credito K, Pankuch GA, Hoellman D, Lin G, Clark C, Dewasse B, McGhee P, Jacobs MR, Appelbaum PC. Antimicrob Agents Chemother; 2004 Nov; 48(11):4113-9. PubMed ID: 15504829 [Abstract] [Full Text] [Related]
3. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae. Mazzariol A, Koncan R, Vitali LA, Cornaglia G. J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779 [Abstract] [Full Text] [Related]
5. In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms. McGhee P, Clark C, Kosowska-Shick KM, Nagai K, Dewasse B, Beachel L, Appelbaum PC. Antimicrob Agents Chemother; 2010 Jan; 54(1):230-8. PubMed ID: 19884376 [Abstract] [Full Text] [Related]
6. Effect of efflux on telithromycin and macrolide susceptibility in Haemophilus influenzae. Bogdanovich T, Bozdogan B, Appelbaum PC. Antimicrob Agents Chemother; 2006 Mar; 50(3):893-8. PubMed ID: 16495248 [Abstract] [Full Text] [Related]
7. Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae and S. pyogenes. Nagai K, Davies TA, Ednie LM, Bryskier A, Palavecino E, Jacobs MR, Appelbaum PC. Antimicrob Agents Chemother; 2001 Nov; 45(11):3242-5. PubMed ID: 11600391 [Abstract] [Full Text] [Related]
8. Time-kill study of the activity of telithromycin against macrolide-resistant Streptococcus pneumoniae Isolates with 23S rRNA mutations and changes in ribosomal proteins L4 and L22. Reinert RR, Al-Lahham A. Antimicrob Agents Chemother; 2005 Jul; 49(7):3011-3. PubMed ID: 15980387 [Abstract] [Full Text] [Related]
10. Emergence of a 23S rRNA mutation in Mycoplasma hominis associated with a loss of the intrinsic resistance to erythromycin and azithromycin. Pereyre S, Renaudin H, Charron A, Bébéar C, Bébéar CM. J Antimicrob Chemother; 2006 Apr; 57(4):753-6. PubMed ID: 16464889 [Abstract] [Full Text] [Related]
11. Expression of the mef(E) gene encoding the macrolide efflux pump protein increases in Streptococcus pneumoniae with increasing resistance to macrolides. Wierzbowski AK, Boyd D, Mulvey M, Hoban DJ, Zhanel GG. Antimicrob Agents Chemother; 2005 Nov; 49(11):4635-40. PubMed ID: 16251306 [Abstract] [Full Text] [Related]